MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/ciac273

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022

Sustained Effect on Hepatitis C Elimination Among Men Who Have Sex With Men in the Swiss HIV Cohort Study: A Systematic Re-Screening for Hepatitis C RNA Two Years Following a Nation-Wide Elimination Program.

Kusejko Katharina, Salazar-Vizcaya Luisa, Shah Cyril, Stöckle Marcel, Béguelin Charles, Schmid Patrick, Ongaro Marie, Darling Katherine, Bernasconi Enos, Rauch Andri, Kouyos Roger D, Günthard Huldrych F, Böni Jürg, Fehr Jan S, Braun Dominique L, Swiss HIV Cohort Study

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The Swiss HCVree Trial (NCT02785666) was conducted in 2015-2017 with the goal of implementing a population-based systematic hepatitis C virus (HCV) micro-elimination program among men who have sex with men (MSM) with human immunodeficiency virus (HIV) enrolled in the Swiss HIV Cohort Study (SHCS). The trial led to a 91% and 77% decline of HCV prevalence and incidence, respectively. The long-term effect of this HCV micro-elimination program is yet to be explored.

METHODS

All MSM enrolled in the SHCS were screened for HCV RNA using stored plasma samples obtained in 2019, termed "Swiss HCVree Post" screen. The incidence of HCV infection over time was assessed using additional information on HCV testing routinely collected in the SHCS. Characteristics of participants with replicating HCV infection were analyzed.

RESULTS

The point-prevalence of "Swiss HCVree Post" (N = 4641) was 0.6%, reflecting a decline of 48% compared to the end of the Swiss HCVree Trial where the prevalence was 1.2%. Further, the incidence of HCV among MSM in the SHCS declined from 0.31/100 person-years (py) (95% confidence interval [CI] [.17, .55]) in 2017 to 0.19/100 py (95% CI [.09, .39]) in 2019.

CONCLUSIONS

A systematic HCV RNA-based screening among MSM with HIV conducted 2 years after the Swiss HCVree Trial revealed a sustained effect and further decline of the prevalence and incidence of replicating HCV infection. This indicates that the Swiss HCVree Trial was successful in curbing the HCV epidemic among MSM with HIV in Switzerland.

CLINICAL TRIALS REGISTRATION: NCT02785666.

Для цитирования: Kusejko Katharina, Salazar-Vizcaya Luisa, Shah Cyril, Stöckle Marcel, Béguelin Charles, Schmid Patrick, Ongaro Marie, Darling Katherine, Bernasconi Enos, Rauch Andri, Kouyos Roger D, Günthard Huldrych F, Böni Jürg, Fehr Jan S, Braun Dominique L, Swiss HIV Cohort Study. Sustained Effect on Hepatitis C Elimination Among Men Who Have Sex With Men in the Swiss HIV Cohort Study: A Systematic Re-Screening for Hepatitis C RNA Two Years Following a Nation-Wide Elimination Program.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022. DOI: 10.1093/cid/ciac273.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.